MISSION STATEMENT
At Integrated Micro-Chromatography Systems (IMCS), we strive to address the growing needs of clinical and research laboratories through innovative technologies and custom solutions that increase testing efficiency. We understand the importance of accuracy, which is why we are committed to delivering to our customers products that consistently provide fast, reliable results. We emphasize safety and security for employees, customers and communities at all times. We communicate with candor in a productive manner to foster teamwork and creativity.
IMCS products help to pave the way for the future of precision medicine.
OUR VISION
As science and technology continue to move the world of biotechnology forward, we are determined to maintain our position as industry leaders that provide high quality, dependable solutions. We dedicate our time to the constant research and improvement necessary to produce efficient tools and services that accelerate the goals of the industries we serve.
IMCS strives to address the growing needs of clinical and research laboratories through advanced technologies that increase testing efficiency and accuracy.
COMPANY HISTORY
IMCS was founded in January 2013, by Andrew Lee, Qian Wang and William Brewer, three Ph.D. scientists from the University of South Carolina. Its rapid success stemmed from the company's unique technology, the founder's experience running companies (DPX Technologies and A&Q NanoDesigns) and support from the city of Columbia, the University of South Carolina and the local USC-Columbia incubator program.
IMCS was a USC/COLA Technology Incubator company and the second tenant of USC IDEA labs. In October 2016, IMCS completed construction of its new state-of-the-art laboratory and administrative headquarters. The multi-million-dollar capital investment by IMCS in infrastructure and equipment has enabled the biotechnology facility and operations center in the Midlands region of South Carolina to increase production capabilities and to expand the development of future products. The added space has allowed IMCS to recruit talented scientists and staff and bring additional cutting-edge products to market. The company continues to grow its facilities in the greater Columbia area.
IMCS creates, manufactures and distributes next-generation biotechnology products to clinical and forensic toxicology, academic research facilities, US Federal Government agencies and health science companies.
Today, IMCS products are used to perform millions of tests monthly and serve more than 700 health science companies across the globe.
